- Presentations
- 2
- Markets
- 1
Adbry is a brand of Tralokinumab marketed by LEO Pharma, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tralokinumab
- Brand owner
- LEO Pharma
- Registered in
- United States
- Strengths and forms
- 150 mg/1 mL injection, 300 mg/2 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Adbry 150 mg/1 mL injectionSubcutaneous Cold chain | LEO Pharma | US FDA | Available on request |
| Adbry 300 mg/2 mL injectionSubcutaneous Cold chain | LEO Pharma | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Adbry
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.